Integra LifeSciences Announces Theken Products Will be Marketed as Integra Spine
PLAINSBORO, N.J., Oct 14, 2008 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that the Theken products will now be marketed under the name Integra Spine(TM), and will be featured at the upcoming North American Spine Society annual meeting, October 15-17, 2008, in Toronto, Canada. The transition to Integra Spine will align the spinal implant business more closely with the Integra corporate brand.
In August 2008, Integra LifeSciences Corporation acquired the Theken companies, which includes Theken Spine, LLC, Theken Disc, LLC and Therics, LLC.
"This is a very exciting opportunity for Integra and Theken, as it allows us to build on our combined strengths and enhances our well recognized Integra corporate brand," said Stuart Essig, Integra's President and CEO. "In addition, with Randy Theken continuing to lead Integra Spine as President, we will ensure the stability and further success of the business."
"As Integra Spine, we look forward to the continued growth of the legacy Theken products and the opportunity to expand our dealer network aggressively," said Randy Theken, President, Integra Spine. "We will demonstrate the same development expertise and customer focus as Theken has in the past."
Integra Spine specializes in pioneering spinal implant technologies that seek to improve spinal surgical techniques, thereby benefiting patients as well as surgeons. Integra Spine provides comprehensive product lines that offer surgeons peace of mind through steadfast product reliability and easy-to-use instrumentation. Products include cervical plates, pedicle screws, spacers, degenerative/deformity, trauma devices, and synthetic bone substitute products. For more information, please visit the Integra Spine website at http://www.integraspine.com.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing and marketing of cost-effective surgical implants and medical instruments. The company's products are used to treat millions of patients every year, primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery. Integra's headquarters are located in Plainsboro, New Jersey, with research and manufacturing facilities throughout the world. www.Integra-LS.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks, uncertainties and reflect Integra's judgment as of the date of this release. Forward-looking statements include, but are not limited to, statements concerning expectations for the strategic benefits that this acquisition will provide to Integra. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, Integra's ability to successfully integrate the Theken business into its own operations could affect the extent of the strategic benefits that Integra generates from this acquisition, and the impact of the acquisition on results of operations, including revenue growth and earnings per share. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item 1A of Integra's Annual Report on Form 10-K for the year ended December 31, 2007 and information contained in subsequent filings with the Securities and Exchange Commission could, affect actual results.
IART- G
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Integra LifeSciences Holdings Corp.
Integra LifeSciences Holdings Corporation
John B. Henneman, III, Executive Vice President, Finance
and Administration, and Chief Financial Officer
(609) 936-2481
jhenneman@Integra-LS.com
Gianna Sabella, Public Relations Manager
(609) 936-2389
gsabella@integra-LS.com
(C) Copyright 2008 GlobeNewswire, Inc. All rights reserved.
News Provided by COMTEX